Gundram Jung

3.7k total citations
114 papers, 2.9k citations indexed

About

Gundram Jung is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Gundram Jung has authored 114 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Immunology, 61 papers in Radiology, Nuclear Medicine and Imaging and 58 papers in Oncology. Recurrent topics in Gundram Jung's work include Monoclonal and Polyclonal Antibodies Research (60 papers), CAR-T cell therapy research (54 papers) and Immune Cell Function and Interaction (24 papers). Gundram Jung is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (60 papers), CAR-T cell therapy research (54 papers) and Immune Cell Function and Interaction (24 papers). Gundram Jung collaborates with scholars based in Germany, United States and Switzerland. Gundram Jung's co-authors include Helmut R. Salih, Hans‐Georg Rammensee, Ludger Große‐Hovest, Chi‐An Chen, Daniel L. Mueller, R H Schwartz, Marc K. Jenkins, Hans J. Müller‐Eberhard, Cyril Honsik and R. Reisfeld and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Gundram Jung

110 papers receiving 2.8k citations

Peers

Countries citing papers authored by Gundram Jung

Since Specialization

Citations

This map shows the geographic impact of Gundram Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gundram Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gundram Jung more than expected).

Fields of papers citing papers by Gundram Jung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gundram Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gundram Jung. The network helps show where Gundram Jung may publish in the future.

Co-authorship network of co-authors of Gundram Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Gundram Jung. A scholar is included among the top collaborators of Gundram Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gundram Jung. Gundram Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bispezifische Antikörper in der Therapie des Prostatakarzinoms 2025 ·PubMed ·Susanne Jung, Jonas S. Heitmann, (unknown), Gundram Jung, Steffen Rausch, Helmut R. Salih	0
2	Targeting CD276 for T cell-based immunotherapy of breast cancer 2024 ·Journal of Translational Medicine ·Ilona Hagelstein, (unknown), (unknown), Latifa Zekri, (unknown), (unknown), Gundram Jung, Christian M. Schürch, Helmut R. Salih, Martina S. Lutz	5
3	Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3) 2024 ·Frontiers in Oncology ·Susanne Jung, Richard F. Schlenk, (unknown), (unknown), Michael Bitzer, (unknown), Juliane S. Walz, Gundram Jung, Jonas S. Heitmann, Helmut R. Salih	2
4	Clinical development of the bispecific PSMAxCD3 antibody CC-1. 2023 ·Journal of Clinical Oncology ·(unknown), Jonas S. Heitmann, Juliane S. Walz, Birgit Federmann, (unknown), Richard F. Schlenk, Sebastian Ochsenreither, Boris Hadaschik, Christopher Darr, Viktor Grünwald, Gundram Jung, Helmut R. Salih	1
5	An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers 2023 ·Molecular Therapy ·Latifa Zekri, Martina S. Lutz, (unknown), (unknown), (unknown), Stefanie Mueller, Sebastian von Hoerner, Ilona Hagelstein, (unknown), (unknown), (unknown), Jonas S. Heitmann, Gundram Jung, Helmut R. Salih	27
6	B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma 2022 ·Frontiers in Immunology ·Ilona Hagelstein, (unknown), Clemens Hinterleitner, (unknown), Melanie Märklin, Gundram Jung, Helmut R. Salih, Latifa Zekri	13
7	CD105 (Endoglin) as negative prognostic factor in AML 2019 ·Scientific Reports ·Joseph Kauer, (unknown), Claudia Tandler, Clemens Hinterleitner, Malte Roerden, Gundram Jung, Helmut R. Salih, Jonas S. Heitmann, Melanie Märklin	21
8	The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid Leukemia 2018 ·Cancer Immunology Research ·Tina Nuebling, (unknown), Martin Hofmann, Ilona Hagelstein, Benjamin Joachim Schmiedel, Stefanie Maurer, Birgit Federmann, Kathrin Rothfelder, Malte Roerden, Daniela Dörfel, Pascal Schneider, Gundram Jung, Helmut R. Salih	46
9	Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody 2016 ·Molecular Therapy ·(unknown), Patrick Schlegel, Ludger Große‐Hovest, Martin Hofmann, Steffen Aulwurm, Elwira Pyż, Friedhelm R. Schuster, Roland Meisel, Martin Ebinger, Tobias Feuchtinger, Heiko‐Manuel Teltschik, (unknown), (unknown), Hans‐Georg Rammensee, Rupert Handgretinger, Gundram Jung, Peter Lang	17
10	An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia 2016 ·Leukemia ·(unknown), Maya C. André, Josef Leibold, Philaretos C. Kousis, André Kübler, Martin Pál, Sebastian P. Haen, (unknown), (unknown), Gundram Jung, (unknown)	48
11	Fc-Optimized NKG2D–Fc Constructs Induce NK Cell Antibody-Dependent Cellular Cytotoxicity against Breast Cancer Cells Independently of HER2/neu Expression Status 2014 ·The Journal of Immunology ·Stefanie Raab, Julia Steinbacher, Benjamin Joachim Schmiedel, Philaretos C. Kousis, Alexander Steinle, Gundram Jung, Ludger Große‐Hovest, Helmut R. Salih	30
12	RANKL Expression, Function, and Therapeutic Targeting in Multiple Myeloma and Chronic Lymphocytic Leukemia 2012 ·Cancer Research ·Benjamin Joachim Schmiedel, (unknown), Tina Nuebling, Hans‐Georg Kopp, Stefan Wirths, Miyuki Azuma, Pascal Schneider, Gundram Jung, Ludger Große‐Hovest, Helmut R. Salih	49
13	Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells 2011 ·Cancer Research ·Theresa Placke, Melanie Örgel, Martin Schaller, Gundram Jung, Hans‐Georg Rammensee, Hans‐Georg Kopp, Helmut R. Salih	350
14	Stimulus Dependence of the Action of Small‐Molecule Inhibitors in the CD3/CD28 Signalling Network 2008 ·ChemMedChem ·Karsten Köhler, (unknown), (unknown), Günter Roth, Ludger Große‐Hovest, Gundram Jung, Roland Brock	0
15	Death receptor-mediated apoptosis in human malignant glioma cells: Modulation by the CD40/CD40L system 2005 ·Journal of Neuroimmunology ·Jörg Wischhusen, Dagmar Schneider, Michel Mittelbronn, Richard Meyermann, Hartmut Engelmann, Gundram Jung, Heinz Wiendl, Michael Weller	28
16	Distribution of labelled anti-tenascin antibodies and fragments after injection into intact or partly resected C6-gliomas in rats 2004 ·Cancer Immunology Immunotherapy ·Claudia Goetz, Walter Rachinger, Markus Decker, Franz‐Josef Gildehaus, Susanne Stocker, Gundram Jung, Klaus Tatsch, (unknown), (unknown)	7
17	Cutting Edge: Predetermined Avidity of Human CD8 T Cells Expanded on Calibrated MHC/Anti-CD28-Coated Microspheres 2003 ·The Journal of Immunology ·Steffen Walter, Leah Herrgen, Oliver Schoor, Gundram Jung, Dorothee Wernet, Hans‐Jörg Bühring, Hans‐Georg Rammensee, Stefan Stevanović	38
18	Anticarcinogenic effect of Kimchi extract on 2-AAF-induced rat hepatocarcinogenesis system 2000 ·KRIBB Repository ·(unknown), (unknown), Gundram Jung	0
19	Bispecific antibody fragments with CD20 × CD28 specificity allow effective autologous and allogeneic T-cell activation against malignant cells in peripheral blood and bone marrow cultures from patients with B-cell lineage leukemia and lymphoma 1999 ·Experimental Hematology ·Martina Brandl, Ludger Große‐Hovest, Ernst Holler, Hans‐Jochem Kolb, Gundram Jung	13
20	Induction of anergy in resting human T lymphocytes by immobilized anti‐CD3 antibodies 1994 ·European Journal of Immunology ·Hans Wolf, Yvonne Müller, (unknown), W. Wilmanns, Gundram Jung	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact